HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Paolo Cravedi Selected Research
Paolo Cravedi Research Topics
Disease
27
Proteinuria
01/2022 - 01/2005
23
Membranous Glomerulonephritis (Membranous Nephropathy)
02/2024 - 07/2006
16
Nephrotic Syndrome (Syndrome, Nephrotic)
01/2024 - 11/2008
11
Kidney Diseases (Kidney Disease)
03/2024 - 07/2009
11
Chronic Kidney Failure (Chronic Renal Failure)
04/2023 - 01/2005
11
COVID-19
11/2022 - 01/2020
10
Chronic Renal Insufficiency
01/2022 - 12/2008
9
Inflammation (Inflammations)
05/2024 - 01/2017
9
Infections
04/2024 - 01/2017
8
Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
12/2023 - 05/2012
8
Hypertension (High Blood Pressure)
01/2021 - 04/2007
7
Neoplasms (Cancer)
01/2022 - 10/2003
6
Albuminuria
01/2020 - 02/2011
5
Disease Progression
03/2024 - 11/2007
5
Glomerulonephritis
07/2023 - 01/2019
5
Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2022 - 05/2012
5
Delayed Graft Function
04/2021 - 01/2005
5
Renal Insufficiency (Renal Failure)
01/2021 - 06/2010
5
Reperfusion Injury
11/2020 - 12/2010
5
Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 07/2007
4
IGA Glomerulonephritis (IGA Nephropathy)
07/2023 - 12/2018
4
Fibrosis (Cirrhosis)
12/2022 - 06/2014
4
Acute Kidney Injury (Acute Renal Failure)
04/2021 - 01/2010
4
Atypical Hemolytic Uremic Syndrome
12/2019 - 05/2012
4
Type 2 Diabetes Mellitus (MODY)
02/2011 - 06/2008
3
Autoimmune Hepatitis
12/2022 - 01/2021
3
Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
12/2018 - 05/2012
2
Immune System Diseases (Immune Disorders)
12/2022 - 02/2009
2
Persistent Infection
01/2022 - 01/2019
2
Hereditary Nephritis (Alport Syndrome)
01/2022 - 01/2015
2
Hyperkalemia
01/2021 - 01/2010
2
Autoimmune Diseases (Autoimmune Disease)
01/2021 - 01/2019
2
Heart Failure
01/2021 - 05/2011
2
Hypoxia (Hypoxemia)
01/2021 - 01/2019
2
Segmental glomerulosclerosis
01/2020 - 12/2018
2
Anemia
09/2014 - 05/2006
2
Hyperlipidemias (Hyperlipidemia)
05/2011 - 12/2010
2
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2010 - 01/2010
1
Hemolytic-Uremic Syndrome
04/2024
1
Atopic Dermatitis (Atopic Eczema)
01/2023
1
Wilms Tumor (Wilm's Tumor)
01/2023
1
Acute Disease
11/2022
Drug/Important Bio-Agent (IBA)
16
Antibodies
IBA
01/2024 - 06/2014
15
Rituximab (Mabthera)
FDA Link
12/2023 - 07/2006
12
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
01/2017 - 11/2007
11
Complement System Proteins (Complement)
IBA
04/2024 - 01/2005
11
Proteins (Proteins, Gene)
FDA Link
01/2022 - 01/2005
10
Biomarkers (Surrogate Marker)
IBA
05/2024 - 01/2010
10
Immunoglobulin G (IgG)
IBA
07/2023 - 01/2005
9
Autoantibodies
IBA
01/2024 - 08/2011
9
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
12/2012 - 07/2006
7
Erythropoietin
FDA Link
01/2023 - 09/2014
7
Steroids
IBA
10/2021 - 01/2011
7
Angiotensin Receptor Antagonists
IBA
01/2015 - 11/2007
5
Monoclonal Antibodies
IBA
04/2023 - 05/2012
5
Creatinine
IBA
01/2022 - 01/2010
4
Immunoglobulin A (IgA)
IBA
07/2023 - 01/2021
4
Antigen-Antibody Complex (Immune Complex)
IBA
07/2023 - 01/2017
4
Cytokines
IBA
11/2022 - 11/2020
4
Immunosuppressive Agents (Immunosuppressants)
IBA
11/2022 - 07/2006
4
Serum Albumin
IBA
01/2021 - 07/2006
4
Antigens
IBA
01/2020 - 08/2011
4
Lipids
IBA
01/2015 - 07/2007
4
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2015 - 11/2010
3
CD55 Antigens (Decay Accelerating Factor)
IBA
01/2023 - 01/2020
3
Chemokines
IBA
11/2022 - 12/2010
3
Immunoglobulin M (IgM)
IBA
10/2021 - 01/2019
3
Albumins
IBA
10/2013 - 10/2003
3
Antihypertensive Agents (Antihypertensives)
IBA
05/2011 - 07/2009
2
COVID-19 Vaccines
IBA
04/2023 - 09/2021
2
Immunoglobulins (Immunoglobulin)
IBA
10/2022 - 12/2021
2
Messenger RNA (mRNA)
IBA
01/2022 - 09/2021
2
Isoantibodies
IBA
10/2021 - 01/2020
2
Hormones (Hormone)
IBA
01/2021 - 01/2020
2
Mineralocorticoid Receptor Antagonists
IBA
01/2021 - 11/2010
2
Alkylating Agents
IBA
01/2019 - 01/2011
2
Calcium Channel Blockers (Blockers, Calcium Channel)
IBA
01/2015 - 02/2011
2
eculizumab
FDA Link
05/2014 - 05/2012
2
CD20 Antigens
IBA
05/2014 - 05/2012
2
trandolapril (Mavik)
FDA Link
Generic
02/2011 - 01/2010
2
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2011 - 01/2005
2
Angiotensin Receptors (Angiotensin II Receptor)
IBA
11/2010 - 07/2009
1
daratumumab
IBA
12/2023
1
galactosyl-deficient IgA1
IBA
07/2023
1
Budesonide (Pulmicort)
FDA Link
Generic
01/2023
1
dupilumab
IBA
01/2023
1
RNA (Ribonucleic Acid)
IBA
01/2023
1
Transaminases (Aminotransferases)
IBA
12/2022
1
Epitopes
IBA
10/2022
1
Immune Checkpoint Inhibitors
IBA
01/2022
1
Cell-Free Nucleic Acids
IBA
01/2022
1
Galactose (Galactopyranose)
FDA Link
Generic
01/2022
Therapy/Procedure
30
Therapeutics
01/2022 - 05/2006
10
Kidney Transplantation
04/2024 - 01/2005
10
Transplantation
04/2024 - 06/2007
4
Organ Transplantation
12/2021 - 01/2020
2
Immunotherapy
12/2021 - 10/2003
2
Peritoneal Dialysis
02/2021 - 05/2011
2
Renal Replacement Therapy (Therapies, Renal Replacement)
01/2021 - 06/2010
1
Blood Component Removal (Apheresis)
06/2022